You can get access to information on Huons and its development of new products

• 50
  Huons Gains IND Approval to initiate Phase 1 Clinical Trial of Anti-obesity Treatment ‘HUC2-676’ in Korea 휴온스 · 2025.12.17
• 49
  Three Affiliates of Huons Group Honored with Export Tower Awards on Trade Day 휴온스 · 2025.12.08
• 48
  Huons Reports Safety and Tolerability Results of New Drug for Dry Eye Syndrome in Phase 1 Clinical Trial 휴온스 · 2025.11.28
• 47
  Huons N to Acquire Health Functional Food Manufacturer ‘Biorosette’ 휴온스 · 2025.11.17
• 46
  PanGen Biotech Reports Q3 2025 Results, Cumulative Sales of 10.94 Billion Won, Operating Profit of 1.91 Billion Won 휴온스 · 2025.11.13
• 45
  Huons Announces 2025 Q3 Results: Growth in Both Sales to 153.7 Billion Won, Operating Profit to 9.9 Billion Won 휴온스 · 2025.11.10
• 44
  Huons to Reduce Price of its Smart Insulin Pen to Improve Accessibility to Diabetes Care 휴온스 · 2025.10.27
• 43
  PanGen Biotech to Renew its GMP Certification in Turkiye “Accelerating Global EPO Biosimilar Business” 휴온스 · 2025.09.25
• 42
  Huons Partners with Therapex to In-License a New Drug Candidate for Lung Cancer 휴온스 · 2025.09.23
• 41
  Huons Selected for National Project for the Stabilizing of the Supply of Orphan Drugs & National Essential Drugs 휴온스 · 2025.09.22
• 40
  Huons' Smart Insulin Pen DIA:CONN P8 Confirmed to Improve Glycemic Control in Clinical Study 휴온스 · 2025.09.08
• 39
  PanGen Biotech Reports Q2 2025 Financial Results with 3.49 Billion won in Revenue and 833 million won in Profit 휴온스 · 2025.08.13
• 38
  Huons posts record high Q2 sales of 156 billion KRW 휴온스 · 2025.08.06
• 37
  Huons N makes Japanese debut, launching vitamins on Qoo10 휴온스 · 2025.06.12
• 36
  PanGen posts Q1 sales of 3.4 billion won and operating profit of 700 million won 휴온스 · 2025.05.14
• 35
  Huons sees limited impact on its exports from Trump’s executive order aiming at lowering drug prices 휴온스 · 2025.05.14
• 34
  Huons Announces Two US FDA Approvals for Multiple-dose Lidocaine Anesthetics 휴온스 · 2025.05.07
• 33
  Huons records Q1 sales of 145.8 billion KRW, operating profit of 12.8 billion KRW 휴온스 · 2025.05.02
• 32
  Huons Group to Launch Specialized Health Functional Food Company ‘Huons N’ 휴온스 · 2025.05.02
• 31
  Huons acquires Authorized Economic Operator (AEO) status from Korea Customs Service 휴온스 · 2025.04.11

All Title Content Writer